Jiksak Bioengineering, Inc. secures 170 Million JPY from ANRI, OHARA Pharmaceutical Co.,Ltd, Essential Pharma Co., Ltd. and MediFuture Co., Ltd. to co
Feb 21, 2018At International Society for Stem cell research (ISSCR) 2017, Jiksak’s technologies was presented in the poster session.
Jun 14, 2017Jiksak Bioengineering Inc. was established in Hongo, Tokyo.
Feb 7, 2017